Melinta Therapeutics

ORBACTIV

Manufacturer:

Melinta Therapeutics

Orbactiv HCPCS:

J2407

HCPCS Code Descriptor:

Injection, oritavancin (orbactiv), 10 mg

Category:

J Code

Orbactiv NDCs:

70842-0140-03

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Orbactiv:

ORBACTIV is an Antibiotic drug manufactured by Melinta Therapeutics and administered via the Intravenous route of administration. The J Code: J2407 is aligned to the drug ORBACTIV.

ORBACTIV is an anti-bacterial drug commonly used to treat acute bacterial and skin structure infections in adult patients. It is a lipoglycopeptide designed to kill Gram positive bacteria through three mechanisms of action: stopping the polymerization step of cell wall synthesis, stopping crosslinking necessary for cell wall synthesis, and disrupting the bacterial cell wall membrane causing eventual bacterial death. ORBACTIV (J2407) is used most commonly in adults and is contraindicated in patients with hepatic or renal insufficiency. Usage of a drug that is metabolized by the CYP450 enzyme is not advised while taking ORBACTIV. Patient assistance can be found through Orbactiv.

ACCESS PRICING AND MORE BY REGISTERING

J2407 Added Date:

January 1, 2016

J2407 Effective Date:

October 1, 2021

J2407 Termination Date:

HCPCS Active

Orbactiv billing and coding information can be found through Melinta Therapeutics at the link below:
Orbactiv patient assistance information can be found through the Orbactiv Patient Support Program at the URL: http://www.orbactiv.com/patient-assistance.html
ORBACTIV prescribing information can be found at the link below:
Information regarding ORBACTIV’s side effects can be found at MedlinePlus